Neurometrix Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

NURO 1.28 -0.03 (-2.29%)
price chart
NeuroMetrix to Unveil Revolutionary Wearable Pain Relief Device at 2015 ...
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders.
Related articles »  
NeuroMetrix Inc.: NeuroMetrix Reports Q1 2015 Financial Results and Highlights
"I'm pleased with the substantial progress we've made throughout the Company, both with DPNCheck and toward a second quarter Quell launch target," said Shai N. Gozani, M.D.
Neurometrix (NURO) Releases Quarterly Earnings Results  The Legacy
NeuroMetrix Inc.: NeuroMetrix, Inc. Announces Date for 2015 First Quarter ...
WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2015 first quarter financial results before the opening of the market on April 21, 2015.
Neurometrix Inc (NURO): Is NeuroMetrix A Good Buy?
NeuroMetrix (NASDAQ:NURO) is a medical device company that develops and markets devices for the treatment and management of the neurological complications of diabetes.
Kenneth J. Snow, M.D., Chief Medical Officer of NeuroMetrix, Inc. Interviewed ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO),, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that its Chief Medical Officer ...
Related articles »  
NeuroMetrix Skyrockets On FDA Approval For Its Wearable Device
NeuroMetrix Inc. (NURO) soared over 30% after the Food and Drug Administration (FDA) approved the company's pain relieving wearable device for over-the-counter sale in the US.
FDA clears NeuroMetrix wearable tech  Boston Globe
With consumer product, NeuroMetrix CEO says he'll need to open a new ...  Boston Business Journal (blog)
Related articles »  
NeuroMetrix to Showcase Quell� Wearable Pain Relief Technology at the 2015 ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) will unveil and demonstrate Quell, a novel wearable pain relief device at the 2015 International Consumer Electronics show (CES) January 6-9 in Las Vegas.
Related articles »  
NeuroMetrix Exceeds Indiegogo Campaign Goal for Quell� Wearable Pain ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) announced that on the day after launch it had exceeded its Quell pre-order thirty day campaign goal.
NeuroMetrix Launches Indiegogo Campaign for Quell� Wearable Pain Relief ...  Yahoo Finance UK
Sabby Management Buys 3 Biotech Stocks
Traders may want to take note of holdings disclosed by Sabby Management LLC to the SEC on Thursday. The firm reported 9.99 percent ownership stakes in the following biotech companies: Neurometrix Inc (NASDAQ: NURO) is a medical device company ...
The Future Of NeuroMetrix
NeuroMetrix was once a Robin Hood story: the company stole from the neurologists, gave to the family practitioners, and made awesome margins in doing so.
Related articles »